Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram-Reference-Cited by-同舟云学术

Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram

Published:2020-10-05 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Liang Wei-feng,Li Hui,Wu Jie-ying,Liu Chang-hao,Wu Miao-fang,Li Jing

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference40 articles.

1. NCCN guidelines insights: Ovarian cancer, version 1.2019;Armstrong;J Natl Compr Canc Netw,2019

2. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Colombo;Ann Oncol.,2019

3. Cancer of the ovary, fallopian tube, and peritoneum;Berek;Int J Gynaecol Obstet.,2018

4. Neoadjuvant chemotherapy for newly diagnosed ovarian cancer: it's all about selection;Dizon;Gynecol Oncol.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high‐grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study;BJOG: An International Journal of Obstetrics & Gynaecology;2022-11

2. Surgical and systemic therapies for addressing occult disease in advanced epithelial ovarian cancer;European Journal of Gynaecological Oncology;2022

3. Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial;BMJ Open;2021-12

4. Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline;JCO Global Oncology;2021-06

5. Current status and future directions of ovarian cancer prognostic models;Journal of Gynecologic Oncology;2021